The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe3+ values

Transfusion Science

Volumn 23, Issue 3, 2000, Pages 201-209

  Hider, Robert C ^a   Liu, Zu D ^a   Piyamongkol, S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Hydroxypyridinone; Iron chelators; pFe3+ value

Indexed keywords

3 HYDROXY 4 PYRIDONE DERIVATIVE; ACETOHYDROXAMIC ACID; CATECHOL; DEFEROXAMINE; IRON BINDING PROTEIN; IRON CHELATING AGENT;

AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG SELECTIVITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON CHELATION; IRON OVERLOAD; STRUCTURE ANALYSIS; TRANSFUSION;

BETA-THALASSEMIA; BLOOD TRANSFUSION; DRUG DESIGN; HEMOSIDEROSIS; IRON CHELATING AGENTS; PYRIDINES;

EID: 0033677747     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(00)00090-4     Document Type: Article

References (35)

1. Iron chelators for thalasaemia
2. Iron chelators for clinical use
3. Complexation of iron by siderophores: A review of their solution and structural chemistry and biological function
4. 3+ values
5. 15Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 500 as probe marker for assessment in vivo of human intestinal permeability
6. The development of iron chelating drugs
7. Improving the oral bioavailability of the iron chelator HBED by breaking the symmetry of the intramolecular H-bond network
8. Pharmacokinetic studies in humans with the oral iron chelator 1,2-dimethyl-3-hydroxypyridin-4-one
9. Lessons from preclinical and clinical studies with 1,2-diethyl-3-hydroxypyridin-4-one, CP94 and related compounds
10. A comparative study of the iron clearing properties of desferrithiocin analogues with desferrioxamine B in a Cebus monkey model
11. A novel oral iron chelator (ICL670A): Results of a phase I single-dose safety study
12. Facilitation of Fe(II) autoxidation by Fe(III) complexing agents
13. Clinically useful chelators of tripositive elements
14. The production of hydroxyl radicals by Deferiprone-iron compounds under physiological conditions
15. Iron chelator chemistry
16. Lipid solubility and drug penetration of the blood brain barrier
17. Metabolism and pharmacokinetics of 1-(2'-trimethylacetoxyethyl)-2-ethyl-3-hydroxypyridi(CP117) (CP117) in the rat
18. Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102): Orally active iron chelators with clinical potential
19. Synthesis and physico-chemical assessment of novel2-substituted-3-hydroxypyridin-4-ones
20. Industrial aspects of iron chelators: Pharmaceutical application
21. Evaluation of desferrithiocin and its synthetic analogues as orally effective iron chelators
22. Desferrithiocin is an effective iron chelator in vivo and in vitro but ferrithiocin is toxic
23. 4-[3,5-bis (2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid: A novel efficient and selective iron(III) complexing agent
24. Urinary metabolic profiles in man and rat of 1,2-dimethyl- and 1,2-diethyl substituted 3-hydroxypyridin-4-ones
25. Development of 3-hydroxypyridin-4-ones which do not undergo extensive phase II metabolism
26. Metabolism and pharmacokinetics of 1-(2'-hydroxyethyl)- and 1-(3'-hydroxypropyl)-2-ethyl-3-hydroxypyridin-4-onesin in the rat
27. In-vivo metabolism of 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one(CP41) (CP41) and 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102) by rat
28. Synthesis, physicochemical properties and biological evaluation of ester prodrugs of 3-hydroxypyridin-4-ones: Design of orally active chelators with clinical potential
29. Design, synthesis, and biological evaluation of aromatic ester prodrugs of 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one(CP41) (CP41) as orally active iron chelators
30. Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats
31. Hydrolytic and metabolic characteristics of the esters of 1- (3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one(CP41), (CP41), potentially useful iron chelators
32. In vivo iron mobilisation evaluation of hydroxypyridinones in 59Fe-ferritin loaded rat model